For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210421:nBw3Y7Sfja&default-theme=true
Form 8.3 - AON PLC Amendment
Ap19
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 19 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
489,112 0.22% 1,725,163 0.76%
(2) Derivatives (other than options):
114,683 0.05% 13,691 0.01%
(3) Options and agreements to
purchase/sell: 24,200 0.01% 24,200 0.01%
TOTAL:
627,995 0.28% 1,763,054 0.78%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 238.1200 USD
Purchase 5 236.1020 USD
Purchase 6 237.7566 USD
Purchase 6 238.0833 USD
Purchase 6 237.3783 USD
Purchase 12 237.9891 USD
Purchase 12 236.2766 USD
Purchase 16 236.5915 USD
Purchase 22 237.1672 USD
Purchase 23 236.4178 USD
Purchase 24 238.0022 USD
Purchase 24 236.5870 USD
Purchase 28 237.6707 USD
Purchase 28 236.8557 USD
Purchase 36 235.9677 USD
Purchase 50 236.1300 USD
Purchase 100 238.6350 USD
Purchase 100 236.2900 USD
Purchase 136 236.2028 USD
Purchase 151 236.1602 USD
Purchase 200 238.6600 USD
Purchase 267 236.9556 USD
Purchase 420 236.7157 USD
Purchase 500 236.1480 USD
Purchase 533 237.6524 USD
Purchase 621 236.5722 USD
Purchase 700 236.1814 USD
Purchase 753 236.6549 USD
Purchase 755 237.6605 USD
Purchase 783 236.1203 USD
Purchase 1,394 235.9050 USD
Purchase 1,607 236.4824 USD
Purchase 2,380 236.2764 USD
Purchase 2,501 236.2756 USD
Purchase 2,640 236.3472 USD
Purchase 4,522 239.1200 USD
Purchase 8,808 236.4161 USD
Purchase 10,044 236.2803 USD
Purchase 10,648 235.8300 USD
Purchase 13,470 236.1236 USD
Purchase 24,161 236.3824 USD
Sale 1 238.5000 USD
Sale 2 235.7700 USD
Sale 2 236.0550 USD
Sale 2 236.0700 USD
Sale 2 237.4400 USD
Sale 3 236.4800 USD
Sale 3 236.1533 USD
Sale 3 235.9233 USD
Sale 3 236.1366 USD
Sale 3 236.1633 USD
Sale 4 236.0525 USD
Sale 5 236.1020 USD
Sale 7 236.3557 USD
Sale 7 236.4164 USD
Sale 7 236.0207 USD
Sale 8 236.2312 USD
Sale 8 236.1137 USD
Sale 10 236.1375 USD
Sale 10 236.2450 USD
Sale 10 236.1100 USD
Sale 18 236.3850 USD
Sale 18 236.2750 USD
Sale 21 237.9971 USD
Sale 22 236.2690 USD
Sale 32 236.5915 USD
Sale 36 236.1550 USD
Sale 81 235.8591 USD
Sale 100 236.2200 USD
Sale 102 236.0660 USD
Sale 103 236.3584 USD
Sale 104 236.5164 USD
Sale 125 236.3377 USD
Sale 133 236.3030 USD
Sale 188 236.9354 USD
Sale 200 237.5625 USD
Sale 200 237.6350 USD
Sale 204 236.2052 USD
Sale 212 236.2118 USD
Sale 243 236.2355 USD
Sale 275 236.1402 USD
Sale 285 236.3161 USD
Sale 293 236.3022 USD
Sale 300 237.7833 USD
Sale 323 236.3452 USD
Sale 355 236.0545 USD
Sale 359 236.2594 USD
Sale 496 236.5416 USD
Sale 606 236.7236 USD
Sale 1,305 235.8491 USD
Sale 1,734 236.1582 USD
Sale 2,108 236.3047 USD
Sale 2,268 236.2454 USD
Sale 4,522 239.1200 USD
Sale 5,563 236.2130 USD
Sale 12,270 236.3408 USD
Sale 14,487 235.8300 USD
Sale 37,534 236.4410 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 21 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -1,200 220.0000 American Jul 16, 2021
Call Options Purchased 1,200 240.0000 American Jul 16, 2021
Call Options Purchased 23,000 220.0000 American Jul 16, 2021
Put Options Purchased -23,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210421005647/en/
(https://www.businesswire.com/news/home/20210421005647/en/)
BARCLAYS PLC
Copyright Business Wire 2021